Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) accounts for over 90% of all pancreatic cancer. Nanoparticles (NPs) offer new opportunities for image-guided therapy owing to the unique physicochemical properties of the nanoscale effect and the multifunctional capabilities of NPs. However, major obstacles ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junjie, Liu, Fengyong, Gupta, Sanjay, Li, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924507/
https://www.ncbi.nlm.nih.gov/pubmed/27375787
http://dx.doi.org/10.7150/thno.15122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924507/
https://www.ncbi.nlm.nih.gov/pubmed/27375787
http://dx.doi.org/10.7150/thno.15122

Ejemplares similares